Treatment of motion sickness in children aged 6–12 years

Clinical scenario

Motion sickness in school-age children aged 6 to 12 years presents distinct management considerations. This age group has specific medication eligibility criteria, and treatment choices differ meaningfully from adult protocols.

Treatment approach

The standard approach involves an antihistamine-class medication taken in advance of travel. A test dose before departure is recommended, as paradoxical reactions can occur in this age group. Certain medications commonly used in adults carry safety concerns in children and should not be used.

Instant Access to Structured Evidence-Based Regimens

References

For children aged 6–12 years, dimenhydrinate (Dramamine for Kids; chewable), 12–25 mg per dose, or diphenhydramine (Benadryl), 0.5–1 mg/kg per dose up to 25 mg, can be given 1–2 hours before travel.

Scopolamine, including patches, can cause dangerous adverse effects such as hallucinations and mental confusion in children and should be avoided.

View source ↗